$5.20
+7.44%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$4.79
From 52W high+0.00%
Volume167657.00
Market cap$24.96M
P/E (TTM)—
P/S (TTM)5523.5x
Div yield—
Key dataSep 18, 2026
Open
$4.79
From 52W high
+0.00%
Volume
167657.00
Market cap
$24.96M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.1x
P/E (TTM)
—
RSI (14)
75.9
MomentumView details →
1D Return
+7.44%
YTD Return
+61.81%
SummaryUpdated Jul 1, 2026
Heart Test Laboratories, Inc. (NASDAQ:HSCS) is a medical technology company founded in 2007 and headquartered in Southlake, Texas. The company went public in June 2022, focusing on developing and commercializing advanced cardiovascular diagnostic devices. Heart Test Laboratories represents an early-stage medical device company attempting to bring innovative electrocardiography technology to market, though it has faced significant challenges in generating meaningful revenue since its public debut.
Similar companies
Latest newsMore news →
HeartSciences reported that its proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with closing expected in the fourth quarter of calendar 2026.5d agoHeartSciences Inc. reported a Q1 loss of $0.86 per share, missing the Zacks Consensus Estimate of a $0.78 loss and improving from a $1.58 loss per share a year earlier.6d ago